首页> 生物试剂> 其他生物试剂> 其他> FLT4 (VEGFR3) 10 UG,PV4129,Invitrogen

FLT4 (VEGFR3) 10 UG,PV4129,Invitrogen

市场价: 询价 / 套
在线询价
优    惠: 请询价
订货号 1LZ8388
品牌型号 Invitrogen PV4129
货期 询货期
最小订货量 1套
联系我们
  • 400-920-3909
  • 商品介绍
  • 规格参数
  • 包装参数
产品介绍 Product Description
规格
Accession Number: NP_891555
Assay Entry: Biochemical phospho-specific activity (no antibody), Biochemical terbium phospho-specific activity, Biochemical europium phospho-specific activity, Biochemical binding/kinetic
Kinase Group: Tyrosine Kinases
Shipping Condition: Dry Ice
System Compatibility: LanthaScreen® Antibody, LanthaScreen® Substrate, Zin-LYTE™, Omnia® Bulk Substrate
Target Entry: FLT4
Target Gene: fms-related tyrosine kinase 4
Expression System: Baculovirus
Protein Family: Kinases & Inhibitors
Protein Form: Recombinant, Cytoplasmic
Protein Subtype: Receptor Tyrosine Kinases
Research Category: Angiogenesis, Signal Transduction
Species: Human
Validated Application: Kinase Assay
Gene ID (Entrez): 10725, 2324
Molecular Weight: 85.2 kDa
Gene Alias: FLT4 (VEGFR3), PCL
KinaseFamily: VEGF Receptors
Protein Length: aa 800-1297; Q890H, V1128L, H1146R
Protein Tag: GST Tag
储存
Storage Buffer: 50 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.02% Triton X-100, 2 mM DTT, 50% Glycerol
Store at -80°C. At first use, aliquot and store at -80°C to avoid multiple freeze-thaws.
描述

FLT4 (VEGFR3), a receptor tyrosine kinase, is a key regulator of embryonic blood vessel development and adult angiogenesis. This kinase has been implicated in juvenile hemangioma, kaposi sarcoma, lymphangiomas, and hereditary lymphedemia.

长度(mm)
宽度(mm)
高度(mm)
重量(kg)
猜你喜欢

在线
客服

在线客服服务时间:09:00-18:00

客服
热线

400-920-3909
客服服务热线 周一至周五(09:00-18:00)

微信
咨询

微信小程序 7X24小时在线咨询